Aclarion stock hits 52-week low at $4.41 amid steep annual decline
In a challenging year for Aclarion, the medical technology company's stock has plummeted to a 52-week low, trading at $4.41. According to InvestingPro data, the company maintains a healthy liquidity ...
Aclarion secures patent for infection, pain biomarker detection
BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company, announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent ...
Aclarion receives U.S. patent on expanded applications of MRS data processing
Aclarion (ACON) has received a Notice of Allowance from the United States Patent and Trademark Office for its 24th issued US patent. Whereas ...